Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

White House will spend $50 billion more on roads, bridges, aviation and water projects

Axion International Holdings, Inc. (AXIH) $2.75 OTCBB

On Tuesday in a new policy initiative, President Obama announced that he wants to spend $50 billion on “needed public works that engage private sector companies, spurring hiring across the country” [emphasis added].

This enormous new spending for “shovel ready” infrastructure projects, on top of the tens of billions of dollars that are still in the pipeline from the original stimulus plans, should have a direct and more immediate impact on many small companies and, ultimately, create new hiring. Read the rest of this entry »

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

Axion International Holdings, Inc. (AXIH) $2.15 OTCBB 

File under compelling examples of “know-how” whose time has come—for this is unquestionably one. Consider the billions of pounds of omnipresent everyday plastic waste, and having it transformed into a building material that doesn’t rot, rust or corrode and is more cost effective and longer lasting than wood, steel or concrete—and it’s 100% environmentally friendly. Read the rest of this entry »

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

UPDATE – Axion International Holdings, Inc. (AXIH) $2.90 OTCBB

The Department of Defense expands its deployment of Axion’s short-span bridges made of 100% recycled plastic

This past week (AXIH) announced the signing of a milestone $957,000 contract with the US Army for the construction of two railroad bridges designed from nearly 100% recycled plastics. With load rating capacities of 130 tons, these bridges reach a whole new level in thermoplastic load bearing capacity. These two bridges will follow Axion’s two recently deployed bridges for tracked and wheeled vehicles at Fort Bragg, NC that are able to support loads of over 73 tons and 88 tons, respectively. Read the rest of this entry »

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

Axion International Holdings, Inc. (AXIH) 2.90 OTCBB

And the chart is in a breakout

(AXIH) is a technology developer that produces a building material that doesn’t rot, rust or corrode and it’s more cost effective and longer lasting than wood, steel or concrete―and it’s 100% environmentally friendly. That’s a mouthful, but there’s even more bling; the material is made from common everyday plastic waste. The story is so good it resonates like an infomercial with a; “Wait, there’s more” tagline. Talk about a story with sizzle, this one really roars. Read the rest of this entry »

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

E-18, Corp. (ETEN) $0.95 OTCBB 

The short and compelling story regarding E-18 Corp (ETEN) is that the company is offering a long-awaited, truly unique “safe needle” to the healthcare industry into a mammoth market at prices only modestly higher than conventional syringes. This “Holy-Grail” breakthrough has the potential for not only solving the problems of needlestick injuries that have for so long been the cause of dread in the healthcare workplace, but for gaining near immediate and significant market share and, importantly, for providing shareholders with a much-improved stock price. Read the rest of this entry »

Arthur Goldgaber
Market Analyst
SmallcapInsights.com

To view the PDF of this white paper, written by Market Analyst Arthur Goldgaber, please click here.

Arthur Goldgaber
Market Analyst
SmallcapInsights.com

To view the PDF of this white paper, written by Market Analyst Arthur Goldgaber, please click here.

Dr. John L. Faessel
ON THE MARKET
Commentary and Insights
Faessel Publishing LLC
Dr.Faessel@onthemar.com

E-18, Corp. (ETEN) $1.01 OTCBB 

E-18 Corp (ETEN) is offering the long-awaited safety solution to the healthcare industry into a mammoth market at prices only modestly higher than conventional syringes …

As a healthcare professional who has given tens of thousands of injections I believe that the truly unique self-sheathing syringe developed by E-18, Corp. (ETEN) is a “Holy-Grail” breakthrough with the potential for not only gaining near immediate and significant market share, but for providing shareholders with a much-improved stock price. Read the rest of this entry »

The Editors
SmallcapInsights.com

If you could invest in a company that produces a patented, disposable medical device with a $5 billion market, and is the only one in its genre that meets the Federal Government’s stringent product mandate, thus requiring healthcare professionals to use it, would you take advantage of the opportunity? Oh, yes, and happens to be manufactured exclusively in the USA?

I’m betting yes. Read the rest of this entry »

The Editors
SmallcapInsights.com

The tricky part about recessions is that the head-in-the-sand approach doesn’t tend to work. Like a serious illness, a recession’s impact on a company has to be addressed early and the ongoing strategy, while perhaps amended, has to plan for post recession. The prognosis of not doing this is indeed dire for the ‘patient’. In this case the patient is the battle weary shareholder.

Let’s do a little background and follow it with a real-world example. Trust me, the latter is well worth the complete read. Read the rest of this entry »